DCTH 10 Bagger journey will start tomorrow after earnings CC, Chemostat sales
Are ramping up at an exceptionally good pace in Europe and soon revenues will make DCTH a cash flow positive company and ODAC panel will give DCTH a favorable green light on May 2,2013 and FDA will follow thru with approval on June 15, 2013. DCTH will be a multi billion dollar cash cow in coming years and will be gobbled up by big pharma in double digits soon after approval. Shorts liver cancer is a very devastating cancer and often patients only survive months after positive diagnosis and any kind of enhancement in patients lives will be approved and in DCTH in phase 3 trials has clearly established a superiority and efficacy greater than current Soc and some patients after the treatment with DCTH device has PFS of 5 years and more . FDA is on a record pace to approve drugs and delivery platforms that enhance Patients lives and DCTH will be approved and garner a major role in fighting many different kinds of cancers!
Dr Tony Montello:
Thank you for your very valuable remarks , remarks from a medical doctor, which I value so much. I hope you write more articles or comments on DCTH, so that we can learn from your knowledge and expertise opinion. I hope more doctors and medical professionals write on DCTH.